Tag: <span>MAO-B Inhibitors</span>

Home / MAO-B Inhibitors
Post

Extended Use of MAO-B Inhibitors Slows Decline in Parkinson’s Disease Patients

Amsterdam, NL, March 6, 2017 – There has long been interest in whether monoamine oxidase type B (MAO-B) inhibitors slow progression of Parkinson’s disease (PD) and improve long-term outcomes. They have shown neuroprotective effects in cell culture and animal studies of PD, but clinical trial results have been mixed and have failed to convincingly demonstrate...